GL Globe Life Inc. Common Stock

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

While Globe Life has outperformed relative to the financial service sector over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

GL's health business is accelerating premium growth, led by United American and Family Heritage, while adding diversification beyond life insurance.

Globe Life (GL) has drawn investor attention after recent share price swings, with the stock closing at $172.16. The move comes against a backdrop of mixed short term returns along with stronger multi year performance. Recent moves tell a mixed story. Globe Life’s share price has eased over the past week and quarter, yet the year to date share price return of 24.38% and five year total shareholder return of 97.35% point to momentum that has been built over a longer horizon. Scan Globe Life...

Globe Life expects premium growth, AI adoption and distribution expansion to support earnings, while strong capital enables substantial share buybacks.

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the life insurance industry, including Globe Life (NYSE:GL) and its peers.

Globe Life Co CEOs Matt Darden + Frank Svoboda join Kristen Scholer on NYSE Live to discuss Company’s Texas Strategy

Globe Life Co-CEOs join Kristen Scholer on NYSE Floor Talk

Insurance providers use their expertise in risk assessment to help protect assets while offering consumers peace of mind through comprehensive coverage options. Market leaders have certainly capitalized on strong underwriting results and rising investment income to boost profitability, helping fuel a 12.3% gain for the industry over the past six months. This performance has closely followed the S&P 500.

Insurance has spent the past 20 years doing many of the things investors usually appreciate, without getting much credit for them. The industry has returned cash through dividends and buybacks, produced relatively dependable earnings, and attracted famous long-term investors such as Warren Buffett. What it has not done particularly well is turn steady business growth into equally strong profit growth. McKinsey estimates that global insurance premiums have grown at an annual rate of about 4.9% si

Globe Life’s 20.2% return over the past six months has outpaced the S&P 500 by 9.3%, and its stock price has climbed to $171.06 per share. This performance may have investors wondering how to approach the situation.

GL's health business gains momentum from strong premium growth, rate increases and expanding distribution, though medical inflation poses risks.

Globe Life (GL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GL's premium growth, rising investment income and AI initiatives support earnings, while higher health claims remain a risk.

Globe Life Inc. recently increased its share repurchase authorization to US$2.50 billion, declared a US$0.33 quarterly dividend for October 2026, and announced the retirement of director David A. Rodriguez for personal reasons. These capital return decisions and board changes came soon after Q2 2026 results highlighted weaker sales trends and underwriting margins despite analyst optimism. Next, we’ll examine how the enlarged buyback authorization interacts with softer underwriting...

Globe Life (GL) is back in focus after its Q2 2026 earnings beat came alongside weaker sales trends and softer underwriting margins, a mix that has kept analyst sentiment cautiously optimistic. See our latest analysis for Globe Life. Globe Life's recent Q2 update and the expanded US$2.5b buyback authorization come after a strong run, with the stock's 90 day share price return of 16.74% and 1 year total shareholder return of 34.73% pointing to momentum that has built over several years. If...

Management put a number on the board so big it forces a question, and the market is paying up as if it's a sure thing.

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

Despite Globe Life’s outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Accident and health insurers face medical-cost pressures, but stronger underwriting, technology adoption and demand for supplemental coverage support growth.

Accident and Health Insurance stocks like AFL, GL, TRUP and EIG are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.

Financial stocks were mixed in Monday afternoon trading, with the NYSE Financial Index decreasing 0.

Aflac's Q2 adjusted EPS misses estimates as lower investment income and FX weigh, but U.S. sales, policy persistency and capital returns offer support.

Manulife Financial posts double-digit core earnings growth as Asia and Global WAM momentum, stronger sales and lower credit loss charges lift Q2 results.

Voya Financial's Q2 earnings fall short as weak alternative investments and severance costs offset fee growth and commercial momentum.

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.

The company raised its outlook on booming AI demand, but the stock is telling a different story by standing still.

Globe Life Co-CEOs Frank Svoboda and Matthew Darden join Inside the ICE House to discuss the company’s focus on providing affordable life and supplemental health insurance to working-class families across America. They explain how Globe Life’s disciplined business model, exclusive agent network, and customer-first approach have driven consistent growth and resilience through changing economic cycles. The conversation also explores the company’s Texas roots, investments in AI and technology, and opportunities to expand in a large underserved market.

Globe Life Inc. recently reported its second-quarter 2026 results, with revenue of US$1,599.73 million and net income of US$287.75 million, and subsequently raised its full-year 2026 net operating earnings guidance to US$15.55–US$15.95 per diluted share, reflecting higher life underwriting margins, stronger health premiums and excess investment income. The updated outlook also factors in potential remeasurement gains of US$110 million to US$130 million from life and health assumption...

Management raised its full-year profit forecast by double digits, but the market seems to be waiting for a second opinion.

Globe Life Inc (GL) reports a 20% increase in net income per share and a robust 7% growth in total premium revenue, despite challenges in life sales and investment portfolio.

Shares of insurance holding company Globe Life (NYSE:GL) fell 7.2% in the afternoon session after the company reported second-quarter earnings that met Wall Street's estimates but failed to excite investors. Revenue rose 6.7% year on year to $1.6 billion, roughly in line with estimates of $1.59 billion. Net premiums earned also matched expectations, coming in at $1.30 billion. On the bottom line, GAAP earnings per share of $3.65 narrowly beat expectations of $3.64. Despite the company meeting es

Globe Life (NYSE:GL) reported higher second-quarter earnings and raised its full-year outlook, with executives pointing to favorable life underwriting trends, growth in health premiums and stronger excess investment income, while also addressing changes in online advertising and agent recruiting. F

GL misses Q2 earnings estimates but raises its 2026 outlook as premium growth, underwriting strength and investment income support results.

Moby summary of Globe Life Inc.'s Q2 2026 earnings call

The headline numbers for Globe Life (GL) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Globe Life (GL) delivered earnings and revenue surprises of -1.64% and +0.22%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Insurance holding company Globe Life (NYSE:GL) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 6.7% year on year to $1.6 billion. Its GAAP profit of $3.65 per share was in line with analysts’ consensus estimates.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Globe Life (GL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.

Insurance holding company Globe Life (NYSE:GL) will be announcing earnings results this Wednesday afternoon. Here’s what to expect.

The company's greatest challenge isn't finding new customers, it's keeping up with the ones it already has, and that's where the real upside could be hiding.

Unum Group's premium growth, technology investments and capital returns support long-term growth, though pricing pressure and higher expenses remain risks.

Globe Life (GL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Globe Life stock has more than doubled over the past five years, and after that kind of run the current checks suggest it no longer looks clearly cheap or clearly expensive, but somewhere in between. Globe Life has returned 105.5% over 5 years, which puts the focus on whether the current share price already reflects most of the good news that investors have been willing to pay for. For a life and health insurer like Globe Life, expectations around steady policy growth and underwriting...

Management is signaling its strongest demand ever, yet the stock's reaction suggests investors are waiting for the other shoe to drop.

Globe Life (GL) has overhauled its financing arrangements, entering into amended and restated credit and term loan agreements that extend maturities, increase borrowing capacity, and shift key administrative roles to Wells Fargo. See our latest analysis for Globe Life. Globe Life’s financing update comes after a steady run in the stock, with the share price return of 7.42% over 30 days and 20.87% over 90 days building on a year-to-date share price return of 29.41% and a 1 year total...